EPA, FDA Agreements Aim To Clear Up Burdensome Regulatory Environment
This article was originally published in The Gray Sheet
Executive SummaryComplex, overlapping federal regulations potentially are blocking availability of innovative disinfectants for medical uses, speakers at a recent Food & Drug Law Institute meeting suggested
You may also be interested in...
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.